Respira Technologies, Inc. announces Jasjit S. Ahluwalia, MD, MPH, MS as Chair of the company's newly formed Scientific Advisory Board.
Retrieved on:
Tuesday, January 18, 2022
Poseidon, Coronavirus Scientific Advisory Board (Turkey), COPD, Research, NDA, Nicotine, Technology, NIH, Diabetes, CADRE, Investigational New Drug, Mortality, Publication, Tobacco, Addiction, Disease, Harm reduction, National Institute on Minority Health and Health Disparities, Smoker, Science, CA, Brown University, IDeA Networks of Biomedical Research Excellence, Death, CEO, VMN, Health equity, IND, Center, Public health, Daněk, Center for Drug Evaluation and Research, View, Pain management, Smoking, Associate, COBRE, Multimedia, Compass rose, Centers of Biomedical Research Excellence, Smoking cessation, FDA, Pharmaceutical industry, Asthma
LOS ANGELES, Calif., Jan. 18, 2022 /PRNewswire/ -- Respira Technologies, Inc. (Los Angeles, CA) announced today, the formation of its Scientific Advisory Board and named Dr. Jasjit ("Jas") S. Ahluwalia as Chair of the newly formed advisory board.
Key Points:
- LOS ANGELES, Calif., Jan. 18, 2022 /PRNewswire/ -- Respira Technologies, Inc. (Los Angeles, CA) announced today, the formation of its Scientific Advisory Board and named Dr. Jasjit ("Jas") S. Ahluwalia as Chair of the newly formed advisory board.
- Danek added, "We are thrilled to name Dr. Ahluwalia as Chair and the founding member of our Scientific Advisory Board.
- He represents one of the best and brightest scientific minds with decades of experience in studying nicotine addiction and cessation.
- Respira is backed by venture firms: Blue Ledge Capital, Compass Rose, DG Ventures, Evolution VC Partners and Poseidon Asset Management.